Jul 21, 2020 Cellectar Announces Poster Presentation of Clinical Data at the American Association of Cancer Research (AACR) Annual Meeting Learn More
Jun 11, 2020 Cellectar to be Granted EU Patent for Phospholipid Ether (PLE) Analogs as Cancer-Targeting Drug Vehicles Learn More
Jun 5, 2020 Cellectar Biosciences Announces Closing of $20 Million Underwritten Public Offering Learn More